Author Topic: (McGill University) Developing the first effective drug for PPMS  (Read 41 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8134
  • MS diagnosed 1980
  • Location: Pacific Northwest
An informative news story about Ocrevus from McGill University in Canada (May 11, 2018), "Developing the first effective drug for progressive MS":


http://publications.mcgill.ca/medenews/2018/05/10/developing-the-first-effective-drug-for-progressive-ms/


This part is something I haven't seen mentioned much elsewhere:




Quote
It should be noted that clinical data came from patients between the ages of 18 and 55.
“It’s not clear how well ocrelizumab works in older people who have had progressive multiple sclerosis for a long time,” cautions Dr. Arnold [a neurologist who worked in the development of ocrelizumab], adding that research continues.
The Multiple Sclerosis Society of Canada notes that “the safety and efficacy of ocrelizumab outside of the age range of 18 to 55 is unknown.” The Society advises older patients who are interested in ocrelizumab to consult their neurologist.
« Last Edit: May 11, 2018, 09:26:36 am by agate »
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
66 Views
Last post March 14, 2016, 12:22:55 pm
by agate
0 Replies
46 Views
Last post May 29, 2016, 04:39:51 pm
by agate
1 Replies
79 Views
Last post February 19, 2017, 03:09:05 pm
by agate
0 Replies
10 Views
Last post August 26, 2018, 08:54:07 pm
by agate
0 Replies
6 Views
Last post May 23, 2019, 09:25:17 pm
by agate